Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 1/2011

01.07.2011 | Gynecologic Oncology

Human papilloma virus persistence and neopterin, folate and homocysteine levels in cervical dysplasias

verfasst von: Faruk Abike, Ayse Basak Engin, İlkkan Dunder, Omer Lutfi Tapisiz, Canan Aslan, Lale Kutluay

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Abstract

Objective

To investigate the relationship between human papilloma virus (HPV) infection persistence and serum folate, vitamin B12, homocysteine, neopterin levels in cervical dysplasia.

Study design

Through the years 2007–2008, 122 women who have admitted to Gynecology Clinic were evaluated for cervical cytology, demographical characteristics, HPV infection, serum folate, vitamin B12, homocysteine, albumin, and neopterin levels.

Results

Considering all the cases, the highest percentage of the HPV-infected patients was in high-grade squamous intraepithelial lesion (HSIL) group (83%, n = 25). The serum folate levels in all patient groups [HSIL 10.0 ± 0.4 ng/ml, low-grade squamous intraepithelial lesion (LSIL) 10.6 ± 0.5 ng/ml, atypical squamous cells-undetermined significance (ASCUS) 11.1 ± 0.8 ng/ml] were lower than control group (11.9 ± 0.5 ng/ml; p < 0.05). The vitamin B12 levels were not significantly altered in any of the patient groups. The serum homocysteine levels in all patient groups (HSIL 10.4 ± 0.5 Umol/l, LSIL 10.1 ± 0.5 Umol/l, ASCUS 10.5 ± 0.7 Umol/l) were higher than the control group (7.9 ± 0.5 Umol/l; p < 0.05). The neopterin levels of HSIL group (1.0 ± 0.2 ng/ml) were lower than the control group (1.5 ± 0.2 ng/ml; p < 0.05). The serum neopterin concentrations of HSIL with HPV group (0.6 ± 0.1 ng/ml) were significantly lower than HSIL without HPV (2.4 ± 0.9 ng/ml) and other study groups (p < 0.05). The serum homocysteine levels of HSIL HPV(+) group and LSIL HPV(+) were higher than control group (p < 0.05). The serum albumin levels of HSIL with HPV group are lower than control and other groups (p < 0.05). In all cervical dysplasia groups, folate levels in patients infected with HPV are lower than in HPV(−) patients (p < 0.05).

Conclusions

Folic acid deficiency could be caused by insufficient cellular immunity. In case of folate deficiency, the predisposition of HPV infection persistency and progression of cervical dysplasia increase. The fact that neopterin is a strong cellular immunity marker and it was detected in patients with HPV persistence and cervical dysplasia in lower levels shows that these patients may have relatively insufficient immune system. In order for dysplasia progression to be prevented, folate fortification on diets may be advised to HPV-infected women.
Literatur
1.
Zurück zum Zitat Ferlay J, Bray F, Pisani P, Parkin DM (2001) GLOBOCAN 2000: cancer incidence, mortality and prevalence worldwide, version 1.0. IARC Press, Lyon Ferlay J, Bray F, Pisani P, Parkin DM (2001) GLOBOCAN 2000: cancer incidence, mortality and prevalence worldwide, version 1.0. IARC Press, Lyon
2.
Zurück zum Zitat Parkin DM, Bray FI, Devesa SS (2001) Cancer burden in the year 2000. The global picture. Eur J Cancer 37(Suppl 8):S4–S66PubMedCrossRef Parkin DM, Bray FI, Devesa SS (2001) Cancer burden in the year 2000. The global picture. Eur J Cancer 37(Suppl 8):S4–S66PubMedCrossRef
3.
Zurück zum Zitat Carter JJ, Koutsky LA, Hughes JP, Lee SK, Kuypers J, Kiviat N et al (2000) Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection. J Infect Dis 181:1911–1919PubMedCrossRef Carter JJ, Koutsky LA, Hughes JP, Lee SK, Kuypers J, Kiviat N et al (2000) Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection. J Infect Dis 181:1911–1919PubMedCrossRef
4.
Zurück zum Zitat Bosch FX, Lorincz A, Munoz N et al (2002) The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55:244–265PubMedCrossRef Bosch FX, Lorincz A, Munoz N et al (2002) The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55:244–265PubMedCrossRef
5.
Zurück zum Zitat Chew GK, Cruickshank ME, Rooney PH, Miller ID, Parkin DE, Murray GI (2005) Human papillomavirus 16 infection in adenocarcinoma of the cervix. Br J Cancer 93:1301–1304PubMedCrossRef Chew GK, Cruickshank ME, Rooney PH, Miller ID, Parkin DE, Murray GI (2005) Human papillomavirus 16 infection in adenocarcinoma of the cervix. Br J Cancer 93:1301–1304PubMedCrossRef
6.
Zurück zum Zitat (2006) IARC monographs on the evaluation of carcinogenic risks to humans, volume 90, human papilloma viruses. International Agency for Research on Cancer, Lyon (2006) IARC monographs on the evaluation of carcinogenic risks to humans, volume 90, human papilloma viruses. International Agency for Research on Cancer, Lyon
7.
Zurück zum Zitat Schiffman M, Castle PE (2003) Human papillomavirus: epidemiology and public health. Arch Pathol Lab Med 127(8):930–934PubMed Schiffman M, Castle PE (2003) Human papillomavirus: epidemiology and public health. Arch Pathol Lab Med 127(8):930–934PubMed
8.
Zurück zum Zitat ASCUS-LSIL Traige Study (ALTS) Group (2003) A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. Am J Obstet Gynecol 188(6):1393–1400 ASCUS-LSIL Traige Study (ALTS) Group (2003) A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. Am J Obstet Gynecol 188(6):1393–1400
9.
Zurück zum Zitat Whitehead N, Reyner F, Lindenbaum J (1973) Megaloblastic changes in the cervical epithelium. J Am Med Assoc 226:1421–1424CrossRef Whitehead N, Reyner F, Lindenbaum J (1973) Megaloblastic changes in the cervical epithelium. J Am Med Assoc 226:1421–1424CrossRef
10.
11.
Zurück zum Zitat Mason JB, Levesque T (1996) Folate: effects on carcinogenesis and the potential for cancer chemoprevention. Oncology (Basel) 10:1727–1742 Mason JB, Levesque T (1996) Folate: effects on carcinogenesis and the potential for cancer chemoprevention. Oncology (Basel) 10:1727–1742
12.
Zurück zum Zitat Weir DG, Scott JM (1999) Cobalamins: physiology, dietary sources and requirements. In: Sadler MJ, Strain JJ, Caballero B (eds) Encyclopedia of human nutrition. Academic Press, London, pp 394–401 Weir DG, Scott JM (1999) Cobalamins: physiology, dietary sources and requirements. In: Sadler MJ, Strain JJ, Caballero B (eds) Encyclopedia of human nutrition. Academic Press, London, pp 394–401
13.
Zurück zum Zitat McPartlin J, Weir DG, Scott JM (1999) Folic acid: physiology, dietary sources and requirements. In: Sadler MJ, Strain JJ, Caballero B (eds) Encyclopedia of human nutrition. Academic Press, London, pp 803–811 McPartlin J, Weir DG, Scott JM (1999) Folic acid: physiology, dietary sources and requirements. In: Sadler MJ, Strain JJ, Caballero B (eds) Encyclopedia of human nutrition. Academic Press, London, pp 803–811
14.
Zurück zum Zitat Flynn MA, Herbert V, Nolph GB, Krause G (1997) Atherogenesis and the homocysteine–folate–cobalamin triad: do we need standardized analyses? J Am Coll Nutr 16:258–267PubMed Flynn MA, Herbert V, Nolph GB, Krause G (1997) Atherogenesis and the homocysteine–folate–cobalamin triad: do we need standardized analyses? J Am Coll Nutr 16:258–267PubMed
15.
Zurück zum Zitat Savage DG, Lindenbaum J, Stabler SP, Allen RH (1994) Sensitivity of serum methylmalonic acid, total homocysteine determinations for diagnosing cobalamin, folate deficiencies. Am J Med 96(3):239–246PubMedCrossRef Savage DG, Lindenbaum J, Stabler SP, Allen RH (1994) Sensitivity of serum methylmalonic acid, total homocysteine determinations for diagnosing cobalamin, folate deficiencies. Am J Med 96(3):239–246PubMedCrossRef
16.
Zurück zum Zitat Weinstein SJ, Ziegler RG, Selhub J, Fears TR, Strickler HD, Brinton LA, Hamman RF, Levine RS, Mallin K, Stolley PD (2001) Elevated serum homocysteine levels and increased risk of invasive cervical cancer in US women. Cancer Causes Control 12(4):317–324PubMedCrossRef Weinstein SJ, Ziegler RG, Selhub J, Fears TR, Strickler HD, Brinton LA, Hamman RF, Levine RS, Mallin K, Stolley PD (2001) Elevated serum homocysteine levels and increased risk of invasive cervical cancer in US women. Cancer Causes Control 12(4):317–324PubMedCrossRef
17.
Zurück zum Zitat Kwaśniewska A, Tukendorf A, Goździcka-Józefiak A, Semczuk-Sikora A, Korobowicz E (2002) Content of folic acid and free homocysteine in blood serum of human papillomavirus-infected women with cervical dysplasia. Eur J Gynaecol Oncol 23(4):311–316PubMed Kwaśniewska A, Tukendorf A, Goździcka-Józefiak A, Semczuk-Sikora A, Korobowicz E (2002) Content of folic acid and free homocysteine in blood serum of human papillomavirus-infected women with cervical dysplasia. Eur J Gynaecol Oncol 23(4):311–316PubMed
18.
Zurück zum Zitat Wachter H, Fuchs D, Hausen A, Reibnegger G, Weiss C, Werner R, Werner-Febmayer C (1992) Neopterin: biochemistry, methods, clinical applications. Walter de Gruyter, New YorkCrossRef Wachter H, Fuchs D, Hausen A, Reibnegger G, Weiss C, Werner R, Werner-Febmayer C (1992) Neopterin: biochemistry, methods, clinical applications. Walter de Gruyter, New YorkCrossRef
19.
Zurück zum Zitat Reibnegger CJ, Bichler AH, Dapunt O, Fuchs DN, Fuith LC, Hausen A, Hetzeb HM, Lutz H, Werner ER, Wachter H (1986) Neopterin as a prognostic indicator in patients with carcinoma of the uterine cervix. Cancer Res 46:950–955PubMed Reibnegger CJ, Bichler AH, Dapunt O, Fuchs DN, Fuith LC, Hausen A, Hetzeb HM, Lutz H, Werner ER, Wachter H (1986) Neopterin as a prognostic indicator in patients with carcinoma of the uterine cervix. Cancer Res 46:950–955PubMed
20.
Zurück zum Zitat Fuchs D, Weiss G, Reibnegger G, Wachter H (1992) The role of neopterin as a monitor of cellular immune activation in transplantation, inflammatory, infectious, and malignant diseases. Crit Rev Clin Lab Sci 29(3–4):307–341PubMedCrossRef Fuchs D, Weiss G, Reibnegger G, Wachter H (1992) The role of neopterin as a monitor of cellular immune activation in transplantation, inflammatory, infectious, and malignant diseases. Crit Rev Clin Lab Sci 29(3–4):307–341PubMedCrossRef
21.
Zurück zum Zitat Polterauer S, Grimm C, Tempfer C, Sliutz G, Speiser P, Reinthaller A, Hefler LA (2007) C-reactive protein is a prognostic parameter in patients with cervical cancer. Gynecol Oncol 107(1):114–117PubMedCrossRef Polterauer S, Grimm C, Tempfer C, Sliutz G, Speiser P, Reinthaller A, Hefler LA (2007) C-reactive protein is a prognostic parameter in patients with cervical cancer. Gynecol Oncol 107(1):114–117PubMedCrossRef
22.
Zurück zum Zitat Yamada N, Nakayama A, Kubota K, Kawakami A, Suzuki E (2008) Structure and function changes of oxidized human serum albumin: physiological significance of the biomarker and importance of sampling conditions for accurate measurement. Rinsho Byori 56(5):409–415PubMed Yamada N, Nakayama A, Kubota K, Kawakami A, Suzuki E (2008) Structure and function changes of oxidized human serum albumin: physiological significance of the biomarker and importance of sampling conditions for accurate measurement. Rinsho Byori 56(5):409–415PubMed
23.
Zurück zum Zitat Chandra S, Chandra RK (1986) Nutrition, immune response, and outcome. Prog Food Nutr Sci 10:1–65PubMed Chandra S, Chandra RK (1986) Nutrition, immune response, and outcome. Prog Food Nutr Sci 10:1–65PubMed
24.
Zurück zum Zitat Dhur A, Galan P, Hercberg S (1991) Folate status and the immune system. Prog Food Nutr Sci 15:43–60PubMed Dhur A, Galan P, Hercberg S (1991) Folate status and the immune system. Prog Food Nutr Sci 15:43–60PubMed
25.
Zurück zum Zitat Wilke CM, Hall BK, Hoge A, Paradee W, Smith DI, Glover TW (1996) FRA3B extends over a broad region and contains a spontaneous HPV 16 integration site: direct evidence for the coincidence of viral integration sites and fragile sites. Hum Mol Genet 5:187–195PubMedCrossRef Wilke CM, Hall BK, Hoge A, Paradee W, Smith DI, Glover TW (1996) FRA3B extends over a broad region and contains a spontaneous HPV 16 integration site: direct evidence for the coincidence of viral integration sites and fragile sites. Hum Mol Genet 5:187–195PubMedCrossRef
26.
Zurück zum Zitat Popescu NC, DiPaolo JA, Amsbaugh SC (1987) Integration sites of human papillomavirus 18 DNA sequences on HeLa cell chromosomes. Cytogenet Cell Genet 44:58–62PubMedCrossRef Popescu NC, DiPaolo JA, Amsbaugh SC (1987) Integration sites of human papillomavirus 18 DNA sequences on HeLa cell chromosomes. Cytogenet Cell Genet 44:58–62PubMedCrossRef
27.
Zurück zum Zitat Piyathilake CJ, Henao OL, Meleth S, Partridge E, Heimburger D (2003) Folate is associated with the acquisition, persistence and clearance of high-risk (HR) human papillomavirus (HPV). FASEB J 17:A373 Piyathilake CJ, Henao OL, Meleth S, Partridge E, Heimburger D (2003) Folate is associated with the acquisition, persistence and clearance of high-risk (HR) human papillomavirus (HPV). FASEB J 17:A373
28.
Zurück zum Zitat Piyathilake CJ, Henao OL, Macaluso M, Cornwell PE, Meleth S, Heimburger DC et al (2004) Folate is associated with the natural history of high-risk human papillomaviruses. Cancer Res 64:8788–8793PubMedCrossRef Piyathilake CJ, Henao OL, Macaluso M, Cornwell PE, Meleth S, Heimburger DC et al (2004) Folate is associated with the natural history of high-risk human papillomaviruses. Cancer Res 64:8788–8793PubMedCrossRef
29.
Zurück zum Zitat Piyathilake CJ, Macaluso M, Brill I, Heimburger DC, Partridge EE (2007) Lower red blood cell folate enhances the HPV-16-associated risk of cervical intraepithelial neoplasia. Nutrition 23(3):203–210PubMedCrossRef Piyathilake CJ, Macaluso M, Brill I, Heimburger DC, Partridge EE (2007) Lower red blood cell folate enhances the HPV-16-associated risk of cervical intraepithelial neoplasia. Nutrition 23(3):203–210PubMedCrossRef
30.
Zurück zum Zitat Kwaśniewska A, Tukendorf A, Semczuk M (1997) Folate deficiency and cervical intraepithelial neoplasia. Eur J Gynaecol Oncol 18(6):526–530PubMed Kwaśniewska A, Tukendorf A, Semczuk M (1997) Folate deficiency and cervical intraepithelial neoplasia. Eur J Gynaecol Oncol 18(6):526–530PubMed
31.
Zurück zum Zitat Piyathilake CJ, Henao OL, Macaluso M, Cornwell PE, Meleth S, Heimburger DC, Partridge EE (2004) Folate is associated with the natural history of high-risk human papillomaviruses. Cancer Res 64(23):8788–8793PubMedCrossRef Piyathilake CJ, Henao OL, Macaluso M, Cornwell PE, Meleth S, Heimburger DC, Partridge EE (2004) Folate is associated with the natural history of high-risk human papillomaviruses. Cancer Res 64(23):8788–8793PubMedCrossRef
32.
Zurück zum Zitat Schroecksnadel K, Frick B, Fiegl M, Winkler C, Denz HA, Fuchs D (2007) Hyperhomocysteinaemia and immune activation in patients with cancer. Clin Chem Lab Med 45(1):47–53PubMedCrossRef Schroecksnadel K, Frick B, Fiegl M, Winkler C, Denz HA, Fuchs D (2007) Hyperhomocysteinaemia and immune activation in patients with cancer. Clin Chem Lab Med 45(1):47–53PubMedCrossRef
33.
Zurück zum Zitat Oner N, Vatansever U, Karasalihoğlu S, Ekuklu G, Celtik C, Biner B (2006) The prevalence of folic acid deficiency among adolescent girls living in Edirne, Turkey. J Adolesc Health 38(5):599–606PubMedCrossRef Oner N, Vatansever U, Karasalihoğlu S, Ekuklu G, Celtik C, Biner B (2006) The prevalence of folic acid deficiency among adolescent girls living in Edirne, Turkey. J Adolesc Health 38(5):599–606PubMedCrossRef
Metadaten
Titel
Human papilloma virus persistence and neopterin, folate and homocysteine levels in cervical dysplasias
verfasst von
Faruk Abike
Ayse Basak Engin
İlkkan Dunder
Omer Lutfi Tapisiz
Canan Aslan
Lale Kutluay
Publikationsdatum
01.07.2011
Verlag
Springer-Verlag
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 1/2011
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-010-1650-7

Weitere Artikel der Ausgabe 1/2011

Archives of Gynecology and Obstetrics 1/2011 Zur Ausgabe

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Menopausale Hormontherapie für Frauen über 65?

07.05.2024 Klimakterium und Menopause Nachrichten

In den USA erhalten nicht wenige Frauen auch noch im Alter über 65 eine menopausale Hormontherapie. Welche positiven und negativen gesundheitlichen Konsequenzen daraus möglicherweise resultieren, wurde anhand von Versicherungsdaten analysiert.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Nodal-negativ nach neoadjuvanter Chemo: Axilladissektion verzichtbar?

03.05.2024 Mammakarzinom Nachrichten

Wenn bei Mammakarzinomen durch eine neoadjuvante Chemotherapie ein Downstaging von nodal-positiv zu nodal-negativ gelingt, scheint es auch ohne Axilladissektion nur selten zu axillären Rezidiven zu kommen.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.